FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including ...
FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including a 67.4% increase in the Rare Diseases portfolio, 9.2% ...
With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market ...
Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a product that is bioequivalent and therapeutically ...
At the inaugural Singapore-New Zealand Judicial Roundtable that took place in Auckland, New Zealand on 7 February 2025, The Honourable the Chief Justice Sundaresh Menon of Singapore led the discussion ...
According to the World Health Organization (WHO), over 22% of the global population smokes, with more than 9 million smoking-related deaths reported annually. Effective treatments to alleviate ...
Given the success of the previous Research Topic 'Exploring Small Molecule Inhibitors in Cardiovascular and Cerebrovascular Diseases', we are pleased to ...
Hena, has been officially inaugurated at San Vinċenz de Paul. This innovative project provides a relaxing space for residents, their families and visitors to unwind and interact with animals. With an ...
Louisville Public Media on MSN14h
His genes forecast Alzheimer's. His brain had other plans.Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback